Search

Author/Creator Blaedel, Julie

1. Carfilzomib in relapsed or refractory multiple myeloma patients with early or late relapse following prior therapy: A subgroup analysis of the randomized phase 3 ASPIRE and ENDEAVOR trials. Issue 2 (15th February 2018)

Authors:
Mateos, Maria‐Victoria; Goldschmidt, Hartmut; San‐Miguel, Jesus; Mikhael, Joseph; DeCosta, Lucy; Zhou, Lifen; Obreja, Mihaela; Blaedel, Julie; Szabo, Zsolt; Leleu, Xavier
Journal:
Hematological oncology
Issue:
Volume 36:Issue 2(2018)
Page Start:
463
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Review of the patient-centered communication landscape in multiple myeloma and other hematologic malignancies. Issue 9 (September 2019)

Authors:
LeBlanc, Thomas W.; Baile, Walter F.; Eggly, Susan; Bylund, Carma L.; Kurtin, Sandra; Khurana, Monica; Najdi, Rani; Blaedel, Julie; Wolf, Jeffrey L.; Fonseca, Rafael
Journal:
Patient education and counseling
Issue:
Volume 102:Issue 9(2019)
Page Start:
1602
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search